Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Dr. Wellmans Homoeopathic Laboratory

Sector: Healthcare | Industry: Drugs & Pharma
R 13.80 0.00  | 0.00% - 16.38 6.99
BSE Price: Nov 14, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Nov 14, 2019 13.80 0.00 0.00% 13.80 13.80 4 13.80 - 13.80
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue0.850.851.070.150.50 -0.25
Other Income0.150.100.060.060.02 0.000.02
Total Income1.000.951.130.210.52 0.000.27
Total Expenditure0.410.700.500.260.34 0.220.44
Operating Profit0.590.250.63-0.050.19 -0.22-0.17
Interest0.050.03--0.00 0.000.00
PBDT0.540.220.63-0.050.19 -0.22-0.17
Depreciation0.090.080.030.040.04 0.040.04
PBT & Exceptional Items0.450.140.60-0.090.15 -0.25-0.20
Exceptional Items0.00---- 0.00-0.00
Profit before Tax0.450.140.60-0.090.15 -0.25-0.21
Provision for Tax0.030.030.12-0.000.03 --
Profit after Tax0.430.110.48-0.080.12 -0.25-0.21
 
LiabilitiesR Cr
Share Capital5.075.075.075.074.88 4.704.70
Total Reserves-2.24-2.15-2.27-2.69-2.62 -2.74-2.49
Shareholder's Funds2.832.922.802.372.26 1.962.21
Long Term Borrowings0.220.250.000.000.00 0.000.00
Other Non Current Liabilities0.000.000.000.000.00 0.000.00
Current Liabilities0.700.710.170.010.04 0.010.04
Total Debt*-0.910.000.000.00 0.000.00
Total Liabilities3.753.882.982.392.30 1.972.24
 
AssetsR Cr
Net Block0.370.410.060.090.13 0.170.15
Non Current Investments0.790.290.290.420.63 --
Other Non-Current Assets1.321.220.280.560.00 0.000.00
Current Investments----- --
Cash and Bank1.151.010.770.160.05 0.060.07
Other Current Assets0.110.951.581.151.48 1.742.02
Net Current Assets0.571.252.181.301.50 1.792.06
Miscellaneous Exp. Not Written Off----- --
Total Assets3.753.882.982.392.30 1.972.24
 
Cash FlowR Cr
From Operations--0.080.270.200.42 0.04-0.31
From Investing Activities--0.34-0.10-0.28-0.61 -0.050.01
From Finance Activities-0.84-0.190.18 -0.22
Net Inflow/Outflow-0.430.170.11-0.01 -0.01-0.07
 
Key Ratios
Adjusted EPS (Rs)0.840.230.95-0.160.24 -0.53-0.44
Adjusted Book Value (Rs)5.585.765.534.684.63 4.174.70
Dividend per Share (Rs)-0.000.000.000.00 0.000.00
Cash Flow per Share (Rs)--0.160.540.390.86 0.09-0.66
Debt to Equity0.080.310.000.000.00 0.000.00
Current Ratio1.812.7613.49108.7539.12 173.8859.47
ROCE (%)-5.1723.17-3.696.96 -12.06-9.38
RONW (%)16.354.0018.60-3.495.67 -12.06-9.39
Operating Margin (%)69.1429.7059.04-32.8236.99 --66.75
Net Margin (%)42.8712.0242.53-38.8822.74 -7,692.04-75.79
Revenue Growth (%)-15.77-20.87629.59-70.63- -100.00-82.16
Net Profit Growth (%)12.07-76.25696.59-167.58147.53 -21.56-131.95
EPS Growth (%)12.06-76.25696.59-165.03145.77 -21.57-130.45
Book Value Growth (%)-4.1718.045.2015.30 -11.380.61
 
Market Cues
Close Price (Rs)----- --
High Price (Rs)----- --
Low Price (Rs)----- --
Market Cap (Rs Cr)6.997.093.170.000.00 -0.00
Price / Earnings16.3862.066.590.000.00 0.000.00
Price / Book Value2.472.431.130.000.00 0.000.00
Dividend Yield (%)0.000.000.00-- --
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
4.63
Piotroski F-Score
2
Modified C-Score
3
1-Year Price to Earnings
16.38
1-Year Price to Book
2.47
Earnings Yield
EBIT / Enterprise value
7.24%
PEG
Price / Earnings to growth ratio
0.15
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,633.35 +0.40%
Caplin Point Laboratories R354.35 -4.26%
Eris Lifesciences R412.50 +0.50%
FDC R193.90 +5.38%
Granules India R128.25 +3.85%
Laurus Labs R337.45 -1.36%
Strides Pharma Science R379.95 +1.19%
Sun Pharma Adv. Research R154.75 +1.91%
Suven Life Sciences R301.70 -2.90%
Wockhardt R296.65 +9.28%
As on Nov 18, 15:59